Dai-ichi Life Insurance Company’s Celestica CLS Stock Holding History

Dai-ichi Life Insurance Company’s Portfolio CLS Stock Details CLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-900	Closed	-$266K	–	471
2025 Q4	$266K	Buy	+900	New	+$271K	0.01%	486

Other funds holding CLS

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

CIBC World Market Toronto, Ontario, Canada $62.3B AUM 44.64% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $52.8B AUM 58.98% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

WRCM

Whale Rock Capital Management Boston, Massachusetts $12.5B AUM 306.52% 1-Year Est. Return

Dai-ichi Life Insurance Company's CLS Position: Q1 2026 in Review

Dai-ichi Life Insurance Company sold out of Celestica (CLS) in Q1 2026, closing a stake of 900 shares — an estimated $266K sold.

Dai-ichi Life Insurance Company first reported a position in CLS in Q4 2025 and held it in 1 quarter. The position peaked at $266K in Q4 2025. 780 funds tracked by Wall St. Rank hold CLS as of Q1 2026.

Dai-ichi Life Insurance Company reported no remaining Celestica position as of Q1 2026 after selling out during the quarter.
Dai-ichi Life Insurance Company sold 900 Celestica shares in Q1 2026, an estimated $266K.
Dai-ichi Life Insurance Company first reported a position in Celestica in Q4 2025 and held it in 1 quarter.
Dai-ichi Life Insurance Company's Celestica position peaked at $266K in Q4 2025.
780 funds tracked by Wall St. Rank held Celestica as of Q1 2026.

Based on Dai-ichi Life Insurance Company's 13F filing for Q1 2026, filed 14 May 2026.